AUTOIMMUNE HEPATITIS
Clinical trials for AUTOIMMUNE HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEPATITIS trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat autoimmune hepatitis?
Disease control CompletedThis study tested a new drug called VAY736 in 68 adults with autoimmune hepatitis, a condition where the immune system attacks the liver. Participants had not responded well to or could not tolerate standard treatments. The goal was to see if VAY736 could help normalize liver enz…
Matched conditions: AUTOIMMUNE HEPATITIS
Phase: PHASE2, PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 04:35 UTC
-
New drug shows promise for autoimmune hepatitis in early trial
Disease control CompletedThis study tested a new drug called zetomipzomib in 24 adults with autoimmune hepatitis, a condition where the immune system attacks the liver. Participants received either the drug or a placebo alongside their usual treatment for 24 weeks, with an option to continue the drug for…
Matched conditions: AUTOIMMUNE HEPATITIS
Phase: PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New MRI scan put to the test for liver disease
Knowledge-focused CompletedThis study checked if a special MRI scan called LiverMultiScan gives the same results when a person is scanned twice on the same machine or on different machines. 61 adults with various liver diseases took part. The goal was to see if the scan reliably measures liver fat, iron, a…
Matched conditions: AUTOIMMUNE HEPATITIS
Sponsor: Perspectum • Aim: Knowledge-focused
Last updated May 17, 2026 04:18 UTC